Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New biomarkers and therapeutics can be discovered during COPD-lung cancer transition.

× No keyword cloud information.

8 in total

Review 1. Autophagy and inflammation.

Authors: Mengjia Qian; Xiaocong Fang; Xiangdong Wang
Journal: Clin Transl Med Date: 2017-07-26

2. Myocyte enhancer factor 2D provides a cross-talk between chronic inflammation and lung cancer.

Authors: Hai-Xing Zhu; Lin Shi; Yong Zhang; Yi-Chun Zhu; Chun-Xue Bai; Xiang-Dong Wang; Jie-Bai Zhou
Journal: J Transl Med Date: 2017-03-24 Impact factor: 5.531

3. Interferon gamma induces inflammatory responses through the interaction of CEACAM1 and PI3K in airway epithelial cells.

Authors: Yichun Zhu; Dongli Song; Yuanlin Song; Xiangdong Wang
Journal: J Transl Med Date: 2019-05-09 Impact factor: 5.531

4. A cellular census of human peripheral immune cells identifies novel cell states in lung diseases.

Authors: Dongli Song; Furong Yan; Huirong Fu; Liyang Li; Jie Hao; Zhenhua Zhu; Ling Ye; Yong Zhang; Meiling Jin; Lihua Dai; Hao Fang; Zhenju Song; Duojiao Wu; Xiangdong Wang
Journal: Clin Transl Med Date: 2021-11

5. Identification of cancer risk assessment signature in patients with chronic obstructive pulmonary disease and exploration of the potential key genes.

Authors: Qingzhou Guan; Peng Zhao; Yange Tian; Liping Yang; Zhenzhen Zhang; Jiansheng Li
Journal: Ann Med Date: 2022-12 Impact factor: 5.348

New biomarkers and therapeutics can be discovered during COPD-lung cancer transition.

Review 1. Autophagy and inflammation.

2. Myocyte enhancer factor 2D provides a cross-talk between chronic inflammation and lung cancer.

3. Interferon gamma induces inflammatory responses through the interaction of CEACAM1 and PI3K in airway epithelial cells.

4. A cellular census of human peripheral immune cells identifies novel cell states in lung diseases.

5. Identification of cancer risk assessment signature in patients with chronic obstructive pulmonary disease and exploration of the potential key genes.

Review 6. The pathophysiological role of mitochondrial oxidative stress in lung diseases.

7. Heterogeneity of lipidomic profiles among lung cancer subtypes of patients.

Review 8. Is the clinical lipidomics a potential goldmine?